Therefore, targeting expression of HEYL (or HEYL-regulated genes/pathways) may be a potential strategy for the development of precision therapies to treat impaired BC stem/progenitor function and airway epithelial remodeling associated with COPD. The gene discussed is HEYL; the disease is chronic obstructive pulmonary disease.